BPC-157 + TB500 Pen
20+20mg
Dhs. 1,425.00
Skip to product information
• In preclinical studies, peptides like BPC‑157 are given daily in small (microgram‑range) doses via intraperitoneal or subcutaneous routes to support tendon and soft tissue healinghttps://pubmed.ncbi.nlm.nih.gov/16583442/
BPC-157 + TB500 Pen
Dhs. 1,425.00
A scientifically formulated peptide combination studied for its role in tissue repair, recovery, and regenerative research. This pairing is widely investigated for musculoskeletal health, localized wound healing, and systemic tissue protection.
Key Features
- 🧪 cGMP manufactured in an FDA-registered facility
- ✅ ≥99% purity confirmed by HPLC analysis
- 📄 Batch-specific Certificates of Analysis (COAs) included
- 💉 Sterile, lyophilized pens for research use only
Human-Relevant Research Applications
💪 Musculoskeletal repair & recovery
• Supports tendon, ligament, and muscle healing
https://pubmed.ncbi.nlm.nih.gov/40756949/
• Supports tendon, ligament, and muscle healing
https://pubmed.ncbi.nlm.nih.gov/40756949/
🩹 Localized wound healing
• Promotes angiogenesis and collagen formation
https://pubmed.ncbi.nlm.nih.gov/41584510/
• Promotes angiogenesis and collagen formation
https://pubmed.ncbi.nlm.nih.gov/41584510/
Mechanism Summary
- BPC-157 modulates VEGF and nitric oxide pathways to enhance tissue vascularization
- TB500 promotes actin cytoskeleton remodeling, improving cellular migration and repair
- The combination provides synergistic tissue regenerative effects suitable for human-relevant studies
Frequently Research Questions
How does this combination compare to using BPC-157 or TB500 alone?
Both peptides target tissue repair, but the combination provides enhanced angiogenesis and early-phase regenerationfor human-relevant studies.
Both peptides target tissue repair, but the combination provides enhanced angiogenesis and early-phase regenerationfor human-relevant studies.
âš¡ Optimal protocol for tendon/soft tissue models
• In preclinical studies, peptides like BPC‑157 are given daily in small (microgram‑range) doses via intraperitoneal or subcutaneous routes to support tendon and soft tissue healinghttps://pubmed.ncbi.nlm.nih.gov/16583442/
Can this combination support systemic repair and recovery?
Yes. Evidence shows collagen synthesis, actin remodeling, and cell migration support systemic tissue repair and recovery. (PubMed)
Yes. Evidence shows collagen synthesis, actin remodeling, and cell migration support systemic tissue repair and recovery. (PubMed)
Scientific References
Legal & Research Disclaimer
This material is supplied exclusively for laboratory research use. It is not intended for diagnostic, therapeutic, cosmetic, human, or veterinary applications. The purchaser assumes all responsibility for compliance with applicable local, state, and federal regulations governing research compounds.